By Max Clarke
The Mayor of London Boris Johnson today opened the new global headquarters of pharmaceutical giant AstraZeneca in Paddington, confirming that the capital is a great location for international businesses.
In a sign of the company’s continued commitment to London, AstraZeneca has moved its current global headquarters across town from Mayfair to brand new and larger offices in the landmark Two Kingdom Street development, Paddington Central. This major boost to London’s business credentials follows the recent announcement by global investment bank JP Morgan, to establish its European headquarters in Canary Wharf.
With close links to many leading London universities, Cancer Research UK and the Medical Research Council, AstraZeneca will employ around 350 people over three floors in its new HQ. This includes 90 staff from its global marketing and sales divisions, some of whom are relocating from its US and Brussels operations.
The Mayor of London, Boris Johnson, said: "It’s no surprise that another great global company is investing in the world’s best city to do business in. What a perfect choice of location they have made in Paddington. This once derelict part of London has transformed itself into a thriving new business district providing quick access to the capital’s transport network, its airports and its centres of world class research. With Crossrail passing through Paddington in the near future, many more businesses will be heading west to reap the huge business benefits AstraZeneca has discovered in this fantastic corner of the capital."
David Brennan, AstraZeneca Chief Executive Officer, said: "We are really delighted that the Mayor of London, Boris Johnson, was able to celebrate with staff as we marked the opening of our new global headquarters. London is a world class city with a vibrant financial centre, with improving transport links and, being based in Paddington, we now have even better access to Heathrow Airport."